Rohini Ravindran Nair
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rohini Ravindran Nair has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Kiran Singh
Banaras Hindu University
14 shared publications Anuradha Khanna
Department of Obstetrics & Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
9 shared publicationsSuresh Singh Yadav
Guru Nanak Dev University, Amritsar, 143005
4 shared publicationsA. Khanna
2 shared publicationsPunita Kalia
Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, India
2 shared publicationsSourav Sharma
Gujarat Biotechnology University, Gandhinagar, Gujarat, 382355
2 shared publications
Latest Publications
- Open Access
Rpl12 paralog dependent TOR-signaling controls the expression of ribosome preservation factor Stm1
Ribosomes are increasingly recognized as heterogeneous regulators of gene expression, yet how ribosomal protein paralogs interface with nutrient signaling remains poorly understood. In Saccharomyces cerevisiae , ribosomal protein gene expression is governed by duplicated gene pairs, many of which exhibit functional divergence despite high sequence identity. A central regulator of ribosome biogenesis and translational control is the Target of Rapamycin (TOR) pathway, which integrates nutrient signals to modulate growth, stress adaptation, and lifespan. Target of Rapamycin Complex 1 (TORC1) influences ribosome activity by phosphorylating ribosomal protein S6 (Rps6), a modification that links nutrient availability to translational output. Here, we investigated the functional divergence of the Rpl12 ribosomal stalk protein paralogs RPL12a and RPL12b and found that rpl12bΔ produces phenotypes consistent with reduced TOR activity, including decreased Rps6 phosphorylation, G2/M cell-cycle accumulation, and significant extension of chronological lifespan as compared to rpl12aΔ and wildtype strain. Multi-omics analyses further indicate translational and metabolic reprogramming consistent with activation of a stress-adaptive program associated with Gcn4. Importantly, loss of RPL12b also reduces levels of the ribosome preservation factor Stm1, a TORC1-regulated protein required for stabilization of 80S ribosomes under stress. This finding links ribosomal stalk composition to ribosome stability and nutrient-responsive signaling. Together, our results demonstrate that ribosomal paralog specialization provides an additional regulatory layer connecting translation, TOR signaling, and cellular longevity.
Open AccessRpl12 paralog dependent TOR-signaling controls the expression of ribosome preservation factor Stm1
Ribosomes are increasingly recognized as heterogeneous regulators of gene expression, yet how ribosomal protein paralogs interface with nutrient signaling remains poorly understood. In Saccharomyces cerevisiae , ribosomal protein gene expression is governed by duplicated gene pairs, many of which exhibit functional divergence despite high sequence identity. A central regulator of ribosome biogenesis and translational control is the Target of Rapamycin (TOR) pathway, which integrates nutrient signals to modulate growth, stress adaptation, and lifespan. Target of Rapamycin Complex 1 (TORC1) influences ribosome activity by phosphorylating ribosomal protein S6 (Rps6), a modification that links nutrient availability to translational output. Here, we investigated the functional divergence of the Rpl12 ribosomal stalk protein paralogs RPL12a and RPL12b and found that rpl12bΔ produces phenotypes consistent with reduced TOR activity, including decreased Rps6 phosphorylation, G2/M cell-cycle accumulation, and significant extension of chronological lifespan as compared to rpl12aΔ and wildtype strain. Multi-omics analyses further indicate translational and metabolic reprogramming consistent with activation of a stress-adaptive program associated with Gcn4. Importantly, loss of RPL12b also reduces levels of the ribosome preservation factor Stm1, a TORC1-regulated protein required for stabilization of 80S ribosomes under stress. This finding links ribosomal stalk composition to ribosome stability and nutrient-responsive signaling. Together, our results demonstrate that ribosomal paralog specialization provides an additional regulatory layer connecting translation, TOR signaling, and cellular longevity.
- 19 January 2026
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 95 (1) , e70203
Role of Myeloid‐Derived Suppressor Cells as a Potential Biomarker in Implanation Failure: A Systematic Review
Background: Pregnancy requires maternal immune tolerance of the semi‐allogeneic fetus without compromising host defense. Myeloid‐derived suppressor cells (MDSCs) have emerged as key regulators of maternal fetal tolerance, but their role in early miscarriage (EM), recurrent pregnancy loss (RPL), and recurrent implantation failure (RIF) remains incompletely defined. Objective: To systematically evaluate the role of MDSCs in EM, RPL, and RIF and assess their potential as biomarkers and therapeutic targets in implantation failure and pregnancy loss. Methodology: A systematic review in accordance with PRISMA guidelines. Searches were conducted in Google Scholar up to April 13, 2025, using the terms “Myeloid Derived Suppressor Cells,” “in vitro fertilization,” “early miscarriage,” “pregnancy loss,” and “implantation failure.” Studies were eligible if they quantified MDSCs in peripheral blood or endometrial samples of women with EM, RPL, or RIF and animal‐only studies. Reviews, abstracts, and inaccessible full texts were excluded. Results: Of 70 records identified, 11 met inclusion criteria (seven human, five murine, one has included human samples and murine models). In human studies, reduced granulocytic MDSCs (G‐MDSCs) were strongly associated with EM and RPL, correlating with low estradiol/progesterone, impaired STAT3 signaling, and a Th1‐dominant cytokine milieu. Findings in RIF were heterogeneous: some reported decreased polymorphonuclear MDSCs with functional impairment, while others observed elevated monocytic MDSCs (M‐MDSCs) with diminished suppressive capacity, suggesting dysfunctional or compensatory expansion. Placental enrichment of G‐MDSCs demonstrated their tolerogenic role in situ, promoting Treg induction and macrophage polarization. Murine models confirmed it as the cause since MDSC depletion abolished pregnancy, while progesterone‐STAT3‐ROS signaling supported their expansion and suppressive function. Adoptive MDSC transfer partially rescued fetal resorption in abortion‐prone models. Conclusions: MDSCs are central to maternal fetal tolerance, and their dysregulation contributes to EM, RPL, and RIF. Human and animal data support their potential as predictive biomarkers and therapeutic targets in implantation failure. Standardization of MDSC phenotyping and mechanistic studies of subset‐specific functions are warranted to advance clinical translation.
- 19 January 2026
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 95 (1) , e70203
Role of Myeloid‐Derived Suppressor Cells as a Potential Biomarker in Implanation Failure: A Systematic Review
Background: Pregnancy requires maternal immune tolerance of the semi‐allogeneic fetus without compromising host defense. Myeloid‐derived suppressor cells (MDSCs) have emerged as key regulators of maternal fetal tolerance, but their role in early miscarriage (EM), recurrent pregnancy loss (RPL), and recurrent implantation failure (RIF) remains incompletely defined. Objective: To systematically evaluate the role of MDSCs in EM, RPL, and RIF and assess their potential as biomarkers and therapeutic targets in implantation failure and pregnancy loss. Methodology: A systematic review in accordance with PRISMA guidelines. Searches were conducted in Google Scholar up to April 13, 2025, using the terms “Myeloid Derived Suppressor Cells,” “in vitro fertilization,” “early miscarriage,” “pregnancy loss,” and “implantation failure.” Studies were eligible if they quantified MDSCs in peripheral blood or endometrial samples of women with EM, RPL, or RIF and animal‐only studies. Reviews, abstracts, and inaccessible full texts were excluded. Results: Of 70 records identified, 11 met inclusion criteria (seven human, five murine, one has included human samples and murine models). In human studies, reduced granulocytic MDSCs (G‐MDSCs) were strongly associated with EM and RPL, correlating with low estradiol/progesterone, impaired STAT3 signaling, and a Th1‐dominant cytokine milieu. Findings in RIF were heterogeneous: some reported decreased polymorphonuclear MDSCs with functional impairment, while others observed elevated monocytic MDSCs (M‐MDSCs) with diminished suppressive capacity, suggesting dysfunctional or compensatory expansion. Placental enrichment of G‐MDSCs demonstrated their tolerogenic role in situ, promoting Treg induction and macrophage polarization. Murine models confirmed it as the cause since MDSC depletion abolished pregnancy, while progesterone‐STAT3‐ROS signaling supported their expansion and suppressive function. Adoptive MDSC transfer partially rescued fetal resorption in abortion‐prone models. Conclusions: MDSCs are central to maternal fetal tolerance, and their dysregulation contributes to EM, RPL, and RIF. Human and animal data support their potential as predictive biomarkers and therapeutic targets in implantation failure. Standardization of MDSC phenotyping and mechanistic studies of subset‐specific functions are warranted to advance clinical translation.
- 13 May 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (6) , 1979-1986
Ethyl Pyruvate as a Potential Therapeutic Agent for Endometriosis: A Perspective
Endometriosis is a disease where vascularised tissue similar to endometrium (the lining of the uterus) grows outside of the uterus. Its pathogenesis involves a complex interplay of inflammation, angiogenesis, cellular proliferation, reactive oxygen species (ROS) production, altered energy metabolism, and epithelial-to-mesenchymal transition (EMT).Even though endometriosis was described more than 150 years ago, we have been unable to find its effective therapy. Conservative treatment approaches like non-steroidal anti-inflammatory drugs or hormone therapy are available to date for the treatment of endometriosis. Anti-angiogenic inhibitors and immunomodulators like IFN-α, β, and TNF-α inhibitors are also potential treatment options. These treatments are inadequate as they either affect the symptoms only of endometriosis or target only one pathological pathway involved. Surgical excision of the endometriotic lesion is also possible, however, recurrence of the disease is reported in several cases. A single therapeutic agent targeting several pathological processes in endometriosis would always be a better option. Here we present our perspective on the pharmacological potential of Ethyl pyruvate and also propose it as a promising therapeutic agent for endometriosis as it inhibits inflammation, cell proliferation, angiogenesis, aerobic glycolysis, EMT, and ROS activity together.
- 13 May 2025
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (6) , 1979-1986
Ethyl Pyruvate as a Potential Therapeutic Agent for Endometriosis: A Perspective
Endometriosis is a disease where vascularised tissue similar to endometrium (the lining of the uterus) grows outside of the uterus. Its pathogenesis involves a complex interplay of inflammation, angiogenesis, cellular proliferation, reactive oxygen species (ROS) production, altered energy metabolism, and epithelial-to-mesenchymal transition (EMT).Even though endometriosis was described more than 150 years ago, we have been unable to find its effective therapy. Conservative treatment approaches like non-steroidal anti-inflammatory drugs or hormone therapy are available to date for the treatment of endometriosis. Anti-angiogenic inhibitors and immunomodulators like IFN-α, β, and TNF-α inhibitors are also potential treatment options. These treatments are inadequate as they either affect the symptoms only of endometriosis or target only one pathological pathway involved. Surgical excision of the endometriotic lesion is also possible, however, recurrence of the disease is reported in several cases. A single therapeutic agent targeting several pathological processes in endometriosis would always be a better option. Here we present our perspective on the pharmacological potential of Ethyl pyruvate and also propose it as a promising therapeutic agent for endometriosis as it inhibits inflammation, cell proliferation, angiogenesis, aerobic glycolysis, EMT, and ROS activity together.
- Open Access
- 8 January 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-16
Analysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases
Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear transport (import and export) of cellular proteins, plays an important role in tumor progression. Exportins, critical mediators of nuclear export, have emerged as potential players in cancer pathogenesis. However, their precise roles and prognostic significance in colon adenocarcinoma remain elusive. This study was designed to comprehensively analyse the expression and prognostic significance of all seven exportins in Colon Adenocarcinoma (COAD) using the online public database. We used public databases UALCAN, C-Bio portal, Human Protein Atlas (HPA), and DAVID, to investigate exportins in COAD patients. Kaplan–Meier plotter, Gene ontology (GO), TIMER, STRING, and KEGG were used to analyse data and draw conclusions. Our observations showed a significant correlation of exportins expression with clinical parameters, used to predict a patient's prognosis in general, such as advancing tumor stage, overall/relapse-free survival, and immune cell infiltrations. Mutation analysis showed the presence of amplifications, missense mutations in XPO2 and XPO4, and deep deletions in XPO7 genes contributing to disease progression and patients survival. This study highlights the potential use of exportins as novel prognostic biomarkers and therapeutic targets for colon adenocarcinoma progression and management.
- 8 January 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-16
Open AccessAnalysis of exportins expression unveils their prognostic significance in colon adenocarcinoma: insights from public databases
Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear transport (import and export) of cellular proteins, plays an important role in tumor progression. Exportins, critical mediators of nuclear export, have emerged as potential players in cancer pathogenesis. However, their precise roles and prognostic significance in colon adenocarcinoma remain elusive. This study was designed to comprehensively analyse the expression and prognostic significance of all seven exportins in Colon Adenocarcinoma (COAD) using the online public database. We used public databases UALCAN, C-Bio portal, Human Protein Atlas (HPA), and DAVID, to investigate exportins in COAD patients. Kaplan–Meier plotter, Gene ontology (GO), TIMER, STRING, and KEGG were used to analyse data and draw conclusions. Our observations showed a significant correlation of exportins expression with clinical parameters, used to predict a patient's prognosis in general, such as advancing tumor stage, overall/relapse-free survival, and immune cell infiltrations. Mutation analysis showed the presence of amplifications, missense mutations in XPO2 and XPO4, and deep deletions in XPO7 genes contributing to disease progression and patients survival. This study highlights the potential use of exportins as novel prognostic biomarkers and therapeutic targets for colon adenocarcinoma progression and management.
- Open Access
Identification of BLM’s Aggregation-Prone Nature and Its Similarity to Intrinsically Disordered Proteins: An In-silico Study
BLM helicase is a member of the RecQ family of DNA helicases, enzymes that play a critical role in maintaining genome stability. The BLM protein is named after Bloom syndrome (BS), a rare genetic disorder caused by mutations in the helicase domain of BLM gene. BLM role has mostly been studied in DNA repair, replication, and recombination; however, a recent study has highlighted the RNA binding capability of the BLM protein. Several proteins, including TDP43, Tau, and alpha-synuclein, are known to play key roles in neurodegenerative diseases. These proteins possess residues prone to parallel aggregation and fibril formation, the key contributor to neurodegenerative disease development. We utilized various in-silico tools like PASTA 2.0, SIFT, PolyPhen 2, and PhD SNP, SNP&GO, Meta-SNP, and SNAP, etc., to identify the molecular signature of the BLM’s protein. Our in-silico analysis suggests that the BLM’s HRDC domain has ability of parallel aggregation and fibril formation. Moreover, structural similarity with proteins like α-synuclein, TDP-43, and Tau and its interactions with PARP1 suggests it may have a role in neurodegenerative diseases. Furthermore, we identified deleterious mutations in the HRDC domain of BLM protein that may compromise its stability and alter its function. Hence, these findings suggest that in addition to BLM’s well-known functions, the protein may have ability to form parallel aggregation and fibril formation and its role in neurodegenerative disease need to further be explored. Author Summary: This paper higlights the importance of considering the structural and physical characteristics of the BLM protein, which may have been previously overlooked in the context of disease pathology. Through in-silico analyses, we identified that the BLM protein possesses residues within the HRDC domain that are prone to parallel aggregation and fibril formation. Moreover, the structural similarity of BLM to proteins such as α-synuclein, TDP-43, and Tau indicates a potential role for BLM in neurodegenerative processes. Additionally, we identified deleterious mutations within the HRDC domain that could compromise the stability of the protein. Furthermore, our findings suggest that the association between BLM and PARP1 may involve a regulatory mechanism that could significantly influence BLM’s function.
Open AccessIdentification of BLM’s Aggregation-Prone Nature and Its Similarity to Intrinsically Disordered Proteins: An In-silico Study
BLM helicase is a member of the RecQ family of DNA helicases, enzymes that play a critical role in maintaining genome stability. The BLM protein is named after Bloom syndrome (BS), a rare genetic disorder caused by mutations in the helicase domain of BLM gene. BLM role has mostly been studied in DNA repair, replication, and recombination; however, a recent study has highlighted the RNA binding capability of the BLM protein. Several proteins, including TDP43, Tau, and alpha-synuclein, are known to play key roles in neurodegenerative diseases. These proteins possess residues prone to parallel aggregation and fibril formation, the key contributor to neurodegenerative disease development. We utilized various in-silico tools like PASTA 2.0, SIFT, PolyPhen 2, and PhD SNP, SNP&GO, Meta-SNP, and SNAP, etc., to identify the molecular signature of the BLM’s protein. Our in-silico analysis suggests that the BLM’s HRDC domain has ability of parallel aggregation and fibril formation. Moreover, structural similarity with proteins like α-synuclein, TDP-43, and Tau and its interactions with PARP1 suggests it may have a role in neurodegenerative diseases. Furthermore, we identified deleterious mutations in the HRDC domain of BLM protein that may compromise its stability and alter its function. Hence, these findings suggest that in addition to BLM’s well-known functions, the protein may have ability to form parallel aggregation and fibril formation and its role in neurodegenerative disease need to further be explored. Author Summary: This paper higlights the importance of considering the structural and physical characteristics of the BLM protein, which may have been previously overlooked in the context of disease pathology. Through in-silico analyses, we identified that the BLM protein possesses residues within the HRDC domain that are prone to parallel aggregation and fibril formation. Moreover, the structural similarity of BLM to proteins such as α-synuclein, TDP-43, and Tau indicates a potential role for BLM in neurodegenerative processes. Additionally, we identified deleterious mutations within the HRDC domain that could compromise the stability of the protein. Furthermore, our findings suggest that the association between BLM and PARP1 may involve a regulatory mechanism that could significantly influence BLM’s function.
- Open Access
Comprehensive Analysis of Exportins Expression and its Prognostic Significance in Colon Adenocarcinoma: Insights from Public Databases
Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear transport (import and export) of cellular proteins, plays an important role in tumor progression. Exportins, critical mediators of nuclear export, have emerged as potential players in cancer pathogenesis. However, their precise roles and prognostic significance in colon adenocarcinoma remain elusive. This study was designed to comprehensively analyse the expression and prognostic significance of all seven exportins in Colon Adenocarcinoma (COAD) using the online public database. We used public databases UALCAN, C-Bio portal, Human Protein Atlas (HPA), and DAVID, to investigate exportins in COAD patients. Kaplan-Meier plotter, Gene ontology (GO), TIMER, STRING, and KEGG were used to analyse data and draw conclusions. Our observations showed a significant correlation of exportins expression with clinical parameters, used to predict a patient’s prognosis in general, such as advancing tumor stage, overall/relapse-free survival, and immune cell infiltrations. Mutation analysis showed the presence of amplifications, missense mutations in XPO2 and XPO4, and deep deletions in XPO7 genes contributing to disease progression and patients survival. This study highlights the potential use of exportins as novel prognostic biomarkers and therapeutic targets for colon adenocarcinoma progression and management.
Open AccessComprehensive Analysis of Exportins Expression and its Prognostic Significance in Colon Adenocarcinoma: Insights from Public Databases
Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear transport (import and export) of cellular proteins, plays an important role in tumor progression. Exportins, critical mediators of nuclear export, have emerged as potential players in cancer pathogenesis. However, their precise roles and prognostic significance in colon adenocarcinoma remain elusive. This study was designed to comprehensively analyse the expression and prognostic significance of all seven exportins in Colon Adenocarcinoma (COAD) using the online public database. We used public databases UALCAN, C-Bio portal, Human Protein Atlas (HPA), and DAVID, to investigate exportins in COAD patients. Kaplan-Meier plotter, Gene ontology (GO), TIMER, STRING, and KEGG were used to analyse data and draw conclusions. Our observations showed a significant correlation of exportins expression with clinical parameters, used to predict a patient’s prognosis in general, such as advancing tumor stage, overall/relapse-free survival, and immune cell infiltrations. Mutation analysis showed the presence of amplifications, missense mutations in XPO2 and XPO4, and deep deletions in XPO7 genes contributing to disease progression and patients survival. This study highlights the potential use of exportins as novel prognostic biomarkers and therapeutic targets for colon adenocarcinoma progression and management.
- Open Access
- 26 January 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1359605
Editorial: Cause or effect: role of inflammation in metabolic disorder
Editorial: Cause or effect: role of inflammation in metabolic disorder
- 26 January 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1359605
Open AccessEditorial: Cause or effect: role of inflammation in metabolic disorder
Editorial: Cause or effect: role of inflammation in metabolic disorder
- Open Access
- 1 July 2021
- Published by School of Studies In Chemistry, Pandit Ravishankar Shukla University
- Vol. 3 (1) , 18-22
Genetic and Epigenetic reprogramming in sperm
Genomic integrity of sperm with stable epigenetic modification is essential for the successful pregnancy outcome. As sperm is subjected to varying degree of chromatin remodeling and regulation its susceptibility for the introduction of various types of errors also increases. Unstable sperm genome and epigenome may arise from improper genome reorganization, altered regulation during spermatogenesis, embryo development and exposures to environmental factors. Introduction of assisted reproductive technologies (ART) has increased our understanding of the role of paternal factors in successful pregnancy. Understanding of the sperm genetic and epigenetic factors is imperative for the improvement of methods in ART, which has far-reaching implications for human reproductive health.
- 1 July 2021
- Published by School of Studies In Chemistry, Pandit Ravishankar Shukla University
- Vol. 3 (1) , 18-22
Open AccessGenetic and Epigenetic reprogramming in sperm
Genomic integrity of sperm with stable epigenetic modification is essential for the successful pregnancy outcome. As sperm is subjected to varying degree of chromatin remodeling and regulation its susceptibility for the introduction of various types of errors also increases. Unstable sperm genome and epigenome may arise from improper genome reorganization, altered regulation during spermatogenesis, embryo development and exposures to environmental factors. Introduction of assisted reproductive technologies (ART) has increased our understanding of the role of paternal factors in successful pregnancy. Understanding of the sperm genetic and epigenetic factors is imperative for the improvement of methods in ART, which has far-reaching implications for human reproductive health.
- Open Access
- 28 April 2017
- Published by Juniper Publishers in Current Trends in Biomedical Engineering & Biosciences
- Vol. 3 (4)
Super-Resolution as a Tool to Understand Nuclear Organization
- 28 April 2017
- Published by Juniper Publishers in Current Trends in Biomedical Engineering & Biosciences
- Vol. 3 (4)
Open AccessSuper-Resolution as a Tool to Understand Nuclear Organization
- 1 February 2017
- Published by Elsevier in General and Comparative Endocrinology
- Vol. 242, 18-23
Immune-endocrine crosstalk during pregnancy
- 1 February 2017
- Published by Elsevier in General and Comparative Endocrinology
- Vol. 242, 18-23
Immune-endocrine crosstalk during pregnancy